title: Evaluation of central nervous system involvement in nasal lymphomas.
abstract: OBJECTIVE
  To clarify the usefulness of evaluating central nervous system (CNS) involvement in patients with nasal lymphomas at the initial staging procedure, and of CNS prophylaxis for patients with clinical stage I/II.
  
  
  METHODS
  We retrospectively reviewed 43 patients with nasal lymphomas who had been treated from 1973 through 1999. The staging procedure included mainly computed tomography (CT), ultrasonography, gallium scintigraphy, upper gastrointestinal study, magnetic resonance (MR) imaging, and bone marrow biopsy. Forty-two patients received radiotherapy, and 25 patients received chemotherapy. All 38 patients with stage I/II were not subjected to CNS prophylaxis.
  
  
  RESULTS
  Four patients demonstrated CNS involvement at the staging procedure. MR imaging demonstrated the tumor had directly infiltrated the skull base in 3 patients, but CT demonstrated CNS infiltration in only one patient. In another patient, cerebrospinal fluid (CSF) cytologic analyses demonstrated CNS involvement, but MR imaging and CT did not. These 4 patients complained of frontonasal pain and/or cerebral nerve dysfunction. No patient with stage I/II developed CNS relapse.
  
  
  CONCLUSIONS
  MR imaging and CSF cytologic analyses should be performed at the initial staging of nasal lymphomas, especially in patients with frontonasal pain and/or cerebral nerve dysfunction. Patients with stage I/II might not need CNS prophylaxis.
authors.affiliation: Department of Radiology, Shinshu University, School of Medicine, Naoto Shikama.
authors.forename: N
authors.initials: N
authors.lastname: Shikama
authors.forename: M
authors.initials: M
authors.lastname: Oguchi
authors.forename: S
authors.initials: S
authors.lastname: Sasaki
authors.forename: A
authors.initials: A
authors.lastname: Shinoda
authors.forename: A
authors.initials: A
authors.lastname: Nishikawa
authors.forename: K
authors.initials: K
authors.lastname: Arakawa
authors.forename: K
authors.initials: K
authors.lastname: Koiwai
authors.forename: K
authors.initials: K
authors.lastname: Mochizuki
authors.forename: A
authors.initials: A
authors.lastname: Yamada
authors.forename: T
authors.initials: T
authors.lastname: Watanabe
authors.forename: M
authors.initials: M
authors.lastname: Kadoya
mesh_terms: D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy / Q000556:secondary*; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology* / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009669:Nose Neoplasms / Q000473:pathology*; D012189:Retrospective Studies